Metastatic Prostate Cancer
Bone metastatic prostate cancer not prognosticated by neuroendocrine cell overexpression
Published in Clinical Oncology Week, June 26th, 2006
"We evaluated the usefulness of overexpression of NE cell differentiation determined by immunohistochemical staining for chromogranin A (Cg A) in diagnostic needle biopsy specimens of bone metastatic prostate cancers. A total of 50 patients diagnosed as having bone metastatic prostate cancer were studied," scientists in Japan reported.
"The period of observation was between 6.9 and 79.4 months (median 48.7 months)," explained Y. Yamada and colleagues, Aichi Medical University. "Cg A was detected by immunostaining using the labeled streptavidin...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Breast Cancer
Breast cancer recurrence risk is not increased after mastectomy and TRAM flap reconstruction - Desmoplastic Melanoma
Desmoplastic melanoma's tendency to recur necessitates narrower excision margins - Disease Associations
Second primary cancer risk in patients who have had transplants was not substantiated - Kidney Tumors
Tumor in solitary kidney treated by open partial nephrectomy - Prostate Cancer
Prostate cancer risk decreased with regular use of non-steroidal anti-inflammatory drug - AIDS-Associated Kaposi Sarcoma
AIDS-associated KS prognostic index predicts mortality at initial diagnosis - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
